[Secondary prevention of coronary heart disease is less agressive in patients over 64 years]

Rev Esp Cardiol. 2003 Jun;56(6):586-93. doi: 10.1016/s0300-8932(03)76920-6.
[Article in Spanish]


Introduction and objectives: Although elderly people has a higher incidence of coronary heart disease, this group is seldom included in clinical trials. Studies performed in Spain on elderly coronary heart disease patients have been conducted in hospital settings. The aim of our study was to analyse wether the management of coronary heart disease patients over 64 years of age cared by family physicians differed from that of the rest.

Patients and method: Cross-sectional multicentre study embedded in a clinical trial on 1,022 patients with stable coronary heart disease in which socio-demographic variables, comorbidity, treatment and cardiovascular risk- factor control were collected.

Results: Mean age was 64 10, 74.0% were men and 53.8% of subjects were over 64 years. Patients over 64 years had a greater cardiovascular comorbidity (87.7 vs 82.6%; p = 0.002) and received lower number of drugs than the rest in the prevention of recurrences (60.4 vs 70.9%; p < 0.001). Probability to receive less than two drugs on secondary prevention by subjects over 64 years was 0.45 (95% CI, 0.30-0.68) despite comorbidity, sex and cardiovascular risk profile.Conclusions. Coronary heart disease patients over 64 years receive less drugs for coronary event recurrence prevention than their younger counterparts despite their worse cardiovascular risk profile.

Publication types

  • English Abstract
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged / psychology*
  • Aged, 80 and over
  • Coronary Disease / epidemiology
  • Coronary Disease / prevention & control*
  • Cross-Sectional Studies
  • Data Collection
  • Family Practice
  • Female
  • Humans
  • Male
  • Middle Aged
  • Spain / epidemiology